Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with exocrine pancreatic cancer, where either a tissue sample or imaging scan suggests it is adenocarcinoma (a specific type of pancreatic cancer)
- People whose cancer is classified as resectable or borderline resectable (meaning surgery to remove the tumour may be possible) according to standard medical guidelines (NCCN guidelines)
- People who are 18 years of age or older at the time of signing the consent form
- People who are in good to very good general physical health, as measured by a standard medical scoring tool called the ECOG scale (scores 0 or 1) (confirm with trial site)
- People who are being considered for chemotherapy, chemoradiotherapy, or direct surgery before or as their main treatment
- People who are able to sign a written consent form and a privacy authorisation form
- People who are expected to live for at least 6 months
Who may not be able to join:
- People whose pancreatic tumour has been confirmed by tissue testing to be a neuroendocrine tumour or any other type of cancer besides adenocarcinoma
- People who are pregnant, have a positive pregnancy test, or are currently breastfeeding
- People who have a significant or uncontrolled heart-related condition that could affect their safety or the results of the study
- People whose cancer has spread to nearby tissues beyond the pancreas (locally advanced) or to other parts of the body (metastatic)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sagila George, University of Oklahoma
Phone: 1-405-271-8777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ctDNA Positivity in Patients with Resectable Pancreatic Cancer; Progression free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.